Literature DB >> 31708489

Evolution of concepts in epilepsy surgery.

Jerome Engel1.   

Abstract

At the time of the first meeting of the International League Against Epilepsy (ILAE) in 1909, surgical treatment for epilepsy had been accepted as an alternative therapy for over two decades, but was rarely practiced, considered a last resort for carefully selected patients. Localization was based on ictal semiology and identification of a structural lesion. Very few papers on epilepsy surgery were presented at ILAE meetings or published in Epilepsia during the first half of the 20th century. A modest explosion in interest in epilepsy surgery at mid-century resulted from recognition that "invisible" epileptogenic lesions could be identified by EEG, especially for temporal lobe epilepsy. Epilepsy surgery received a second boost in popularity toward the end of the 20th century with the advent of structural and functional neuroimaging, and the number of epilepsy centers worldwide doubled between the first Palm Desert conference in 1986 and the second Palm Desert conference in 1992. Neuroimaging also helped to increase application of surgical treatment to infants and young children with severe epilepsies. Epilepsy surgery was accepted as standard of care for drug-resistant focal epilepsy and was well-represented at international ILAE congresses and in Epilepsia. Advances continue into the 21st century with the introduction of laser ablation, and palliative neuromodulation approaches, which have greatly increased the population of patients who can benefit from surgery. Modern presurgical evaluation techniques have also made surgical treatment possible in many countries with limited resources. Three randomized control trials now have definitively proved the safety and efficacy of epilepsy surgery, however, this alternative therapy remains under-utilized even in the industrialized world, where less than 1% of potential candidates are being referred to epilepsy centers. Furthermore, those who are referred receive surgery an average of 20 years after onset of epilepsy, often too late to avoid irreversible disability. The major challenges in realizing the full potential of epilepsy surgery, therefore, are not as much in the continued improvement of the treatment itself, as they are in addressing the treatment gap that is preventing appropriate patients from being referred to full-service epilepsy centers.

Entities:  

Keywords:  EEG; ILAE; epilepsy surgery; history; neuroimaging; neuropsychological testing

Mesh:

Year:  2019        PMID: 31708489     DOI: 10.1684/epd.2019.1091

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  5 in total

Review 1.  The surgical treatment of epilepsy.

Authors:  Alessandro Consales; Sara Casciato; Sofia Asioli; Carmen Barba; Massimo Caulo; Gabriella Colicchio; Massimo Cossu; Luca de Palma; Alessandra Morano; Giampaolo Vatti; Flavio Villani; Nelia Zamponi; Laura Tassi; Giancarlo Di Gennaro; Carlo Efisio Marras
Journal:  Neurol Sci       Date:  2021-04-02       Impact factor: 3.307

2.  [18F]FDG PET/MRI and magnetoencephalography may improve presurgical localization of temporal lobe epilepsy.

Authors:  Kun Guo; Jingjuan Wang; Bixiao Cui; Yihe Wang; Yaqin Hou; Guoguang Zhao; Jie Lu
Journal:  Eur Radiol       Date:  2021-10-14       Impact factor: 5.315

Review 3.  Stereo-Encephalographic Presurgical Evaluation of Temporal Lobe Epilepsy: An Evolving Science.

Authors:  Elma Paredes-Aragon; Norah A AlKhaldi; Daniel Ballesteros-Herrera; Seyed M Mirsattari
Journal:  Front Neurol       Date:  2022-05-27       Impact factor: 4.086

4.  Epilepsy in adult patients with tuberous sclerosis complex.

Authors:  Aglaia Vignoli; Francesca La Briola; Katherine Turner; Angela Peron; Chiara Vannicola; Valentina Chiesa; Elena Zambrelli; Fabio Bruschi; Ilaria Viganò; Maria Paola Canevini
Journal:  Acta Neurol Scand       Date:  2021-03-22       Impact factor: 3.209

5.  Current Status and Future Objectives of Surgical Therapies for Epilepsy in Japan.

Authors:  Nobuhiro Mikuni; Naotaka Usui; Hiroshi Otsubo; Kensuke Kawai; Haruhiko Kishima; Taketoshi Maehara; Seiichiro Mine; Takamichi Yamamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-10-08       Impact factor: 1.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.